Cargando…

Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverter‐Defibrillators in the Cardiovascular Research Network

BACKGROUND: Primary prevention implantable cardioverter‐defibrillators (ICDs) reduce mortality in selected patients with left ventricular systolic dysfunction by delivering therapies (antitachycardia pacing or shocks) to terminate potentially lethal arrhythmias; inappropriate therapies also occur. W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Greenlee, Robert T., Go, Alan S., Peterson, Pamela N., Cassidy‐Bushrow, Andrea E., Gaber, Charles, Garcia‐Montilla, Romel, Glenn, Karen A., Gupta, Nigel, Gurwitz, Jerry H., Hammill, Stephen C., Hayes, John J., Kadish, Alan, Magid, David J., McManus, David D., Multerer, Deborah, Powers, J. David, Reifler, Liza M., Reynolds, Kristi, Schuger, Claudio, Sharma, Param P., Smith, David H., Suits, Mary, Sung, Sue Hee, Varosy, Paul D., Vidaillet, Humberto J., Masoudi, Frederick A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5907599/ https://www.ncbi.nlm.nih.gov/pubmed/29581222 http://dx.doi.org/10.1161/JAHA.117.008292

Ejemplares similares

Comparison of Inappropriate Shocks and Other Health Outcomes Between Single‐ and Dual‐Chamber Implantable Cardioverter‐Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter‐Defibrillators
por: Peterson, Pamela N., et al.
Publicado: (2017)

Age and Sex Differences in Long-Term Outcomes Following Implantable Cardioverter-Defibrillator Placement in Contemporary Clinical Practice: Findings From the Cardiovascular Research Network
por: Masoudi, Frederick A, et al.
Publicado: (2015)

Atrial Fibrillation and Outcomes in Heart Failure With Preserved Versus Reduced Left Ventricular Ejection Fraction
por: McManus, David D., et al.
Publicado: (2013)

Trends in Use of Single- vs Dual-Chamber Implantable Cardioverter-Defibrillators Among Patients Without a Pacing Indication, 2010-2018
por: Borne, Ryan T., et al.
Publicado: (2022)

Implantable Cardioverter‐Defibrillators for Secondary Prevention of Sudden Cardiac Death: A Review
por: Borne, Ryan T., et al.
Publicado: (2017)

Primary prevention implantable cardioverter defibrillator in cardiac resynchronization therapy recipients with advanced chronic kidney disease
por: Goldenberg, Ido, et al.
Publicado: (2023)

Adherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart disease
por: Ho, P Michael, et al.
Publicado: (2006)

Novel predictors of permanent pacemaker implantation following transcatheter aortic valve replacement
por: Nwaedozie, Somto, et al.
Publicado: (2023)

Trends in Short‐, Intermediate‐, and Long‐Term Mortality Following Hospitalization for Myocardial Infarction Among Medicare Beneficiaries, 2008 to 2018
por: Kini, Vinay, et al.
Publicado: (2023)

Usage of the wearable cardioverter-defibrillator during pregnancy
por: Olic, J.-Jacqueline, et al.
Publicado: (2022)

Milestones in Oculofacial Plastic and Reconstructive Surgery: The Discovery of the Levator Palpebrae Superioris and Its Subsequent History
por: Reifler, David M.
Publicado: (2020)

Low Body Mass Index but Not Obesity Is Associated With In-Hospital Adverse Events and Mortality Among Implantable Cardioverter-Defibrillator Recipients: Insights From the National Cardiovascular Data Registry
por: Hsu, Jonathan C., et al.
Publicado: (2012)

Discrimination against international medical graduates in the United States residency program selection process
por: Desbiens, Norman A, et al.
Publicado: (2010)

The impact of primary immunization route on the outcome of infection with SARS-CoV-2 in a hamster model of COVID-19
por: Barrett, Edward G., et al.
Publicado: (2023)

Remote monitoring and follow-up of pacemakers and implantable cardioverter defibrillators
por: Burri, Haran, et al.
Publicado: (2009)

Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator—The PROLONG Study
por: Duncker, David, et al.
Publicado: (2017)

Trends in High- and Low-Value Cardiovascular Diagnostic Testing in Fee-for-Service Medicare, 2000-2016
por: Kini, Vinay, et al.
Publicado: (2019)

Outer Limits of Biotechnologies: A Jewish Perspective
por: Loike, John D., et al.
Publicado: (2018)

Expression profiling: a cost-effective biomarker discovery tool for the personal genome era
por: Gurwitz, David
Publicado: (2013)

Human iPSC-derived neurons and lymphoblastoid cells for personalized medicine research in neuropsychiatric disorders
por: Gurwitz, David
Publicado: (2016)

Genomics and the future of psychopharmacology: MicroRNAs offer novel therapeutics 
por: Gurwitz, David
Publicado: (2019)

COVID-19 vaccine hesitancy: Lessons from Israel
por: Gurwitz, David
Publicado: (2021)

Ethical tradeoffs in SARS-CoV-2 vaccine development: Assuring fair availability for low-income countries
por: Gurwitz, David
Publicado: (2021)

Implantable Cardioverter‐Defibrillator Shocks During COVID‐19 Outbreak
por: Adabag, Selçuk, et al.
Publicado: (2021)

Three-year chronic follow-up from the pilot study of a substernal extravascular implantable cardioverter-defibrillator
por: Crozier, Ian, et al.
Publicado: (2023)

Increase in the proportion of patients hospitalized with acute myocardial infarction with do-not-resuscitate orders already in place between 2001 and 2007: a nonconcurrent prospective study
por: Saczynski, Jane S, et al.
Publicado: (2012)

Patterns of beta-blocker intensification in ambulatory heart failure patients and short-term association with hospitalization
por: Allen, Larry A, et al.
Publicado: (2012)

Maternal-Cord Blood Vitamin D Correlations Vary by Maternal Levels
por: Wegienka, Ganesa, et al.
Publicado: (2016)

Editorial: Allergic diseases and neurodevelopment
por: Straughen, Jennifer K., et al.
Publicado: (2023)

BAYESIAN META-ANALYSIS ON MEDICAL DEVICES: APPLICATION TO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
por: Youn, Ji-Hee, et al.
Publicado: (2012)

Incidence, Predictors, and Outcomes of Implantable Cardioverter‐Defibrillator Discharge Among People Living With HIV
por: Alvi, Raza M., et al.
Publicado: (2018)

The impact of diabetes on one-year health status outcomes following acute coronary syndromes
por: Peterson, Pamela N, et al.
Publicado: (2006)

Comparison of zero fluoroscopy versus fluoroscopy guided ablation for atrial fibrillation: A single center experience
por: Jimenez Restrepo, A, et al.
Publicado: (2023)

Serum-Based Oxylipins Are Associated with Outcomes in Primary Prevention Implantable Cardioverter Defibrillator Patients
por: Zhang, Yiyi, et al.
Publicado: (2016)

Predictors of early mortality in implantable cardioverter-defibrillator recipients
por: Stein, Kenneth M., et al.
Publicado: (2009)

Evolving use and indications for implantable cardioverter defibrillators
por: de Groot, J. R.
Publicado: (2018)

Prenatal physical activity and the gut microbiota of pregnant women: results from a preliminary investigation
por: Santarossa, Sara, et al.
Publicado: (2023)

Differences in High‐ and Low‐Value Cardiovascular Testing by Health Insurance Provider
por: Kini, Vinay, et al.
Publicado: (2021)

Psychological factors and cardiac repolarization instability during anger in implantable cardioverter defibrillator patients
por: Krantz, David S., et al.
Publicado: (2021)

Life‐threatening and life‐saving inappropriate implantable cardioverter defibrillator shocks
por: Pérez‐Rodon, Jordi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dkfn53l3pl78adg7dbvarm2rnl